Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 2/2018

01-04-2018 | Correction

Correction to: The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on the Response to Warfarin in Egyptians

Authors: Ahmed M. L. Bedewy, Salah A. Sheweita, Mostafa Hasan Mostafa, Lamia Saeed Kandil

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 2/2018

Login to get access

Excerpt

The aim of this erratum is to acknowledge that the original version of this article was inadvertently published with incorrect author name and affiliation for a co-author. The correct name and affiliation should read as Salah A. Sheweita, Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Egypt. The submitting author, Dr. Bedewy, regrets this error. …
Metadata
Title
Correction to: The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on the Response to Warfarin in Egyptians
Authors
Ahmed M. L. Bedewy
Salah A. Sheweita
Mostafa Hasan Mostafa
Lamia Saeed Kandil
Publication date
01-04-2018
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2018
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-018-0946-9

Other articles of this Issue 2/2018

Indian Journal of Hematology and Blood Transfusion 2/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine